MALARIA
Clinical trials for MALARIA explained in plain language.
Never miss a new study
Get alerted when new MALARIA trials appear
Sign up with your email to follow new studies for MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major malaria vaccine trial shows promise for african children
⭐️ VACCINE ⭐️ OngoingThis large Phase 3 trial is testing whether the R21/Matrix-M vaccine can protect young children (5-36 months old) from getting malaria. About 4800 children in Africa are taking part. The study compares vaccinated children to those who did not get the vaccine to see if the shot sa…
Matched conditions: MALARIA
Phase: PHASE3 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:32 UTC
-
Genetically altered malaria vaccine moves to human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new malaria vaccine made from genetically weakened malaria parasites. The goal is to see if it is safe and can train the immune system to fight malaria without causing the disease. Up to 22 healthy adults who have never had malaria will receive the …
Matched conditions: MALARIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:30 UTC
-
Could a shot plus a vaccine stop malaria in babies?
⭐️ VACCINE ⭐️ OngoingThis study tests whether giving infants an experimental antibody (L9LS) before a malaria vaccine is safe and helps the vaccine work better. About 180 babies in Mali, aged 1 to 12 months, will receive either L9LS or a placebo, then the R21/Matrix-M vaccine. Researchers will monito…
Matched conditions: MALARIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 15:59 UTC
-
Could a malaria vaccine be safe for Moms-to-Be? new trial aims to find out
⭐️ VACCINE ⭐️ TerminatedThis study tests whether an experimental malaria vaccine (PfSPZ) is safe for pregnant women. Malaria can cause serious problems during pregnancy, including miscarriage and early delivery. The trial will involve 400 healthy pregnant women in Mali, some receiving the vaccine and ot…
Matched conditions: MALARIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:41 UTC
-
New mosquito nets could slash malaria cases in west africa
Disease control OngoingThis study tests two new types of mosquito nets (Interceptor G2 and Veeralin) against standard nets to see if they better prevent malaria in children aged 6 months to 10 years and adults in central Côte d'Ivoire. About 1,650 people are taking part, and researchers track malaria c…
Matched conditions: MALARIA
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New study aims to outsmart malaria by blocking it early in life
Disease control OngoingThis study tests whether giving young children monthly malaria prevention medicine (dihydroartemisinin-piperaquine) from 8 weeks old up to 1 or 2 years of age can help their bodies build stronger immunity against malaria. About 924 children in Uganda will be followed until age 4 …
Matched conditions: MALARIA
Phase: PHASE3 • Sponsor: Grant Dorsey, M.D, Ph.D. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC
-
Liberia malaria study aims to clear path for vaccine
Knowledge-focused OngoingThis study tracks how often people of all ages in two Liberian villages get malaria. Researchers will test blood monthly and check homes for mosquitoes. The goal is to gather data that could help use a future malaria vaccine more effectively. About 396 healthy residents aged 6 mo…
Matched conditions: MALARIA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Malaria vaccine study pulled before it began
Knowledge-focused TerminatedThis study was designed to see if giving a lab-made antibody (L9LS) before a malaria vaccine (R21/Matrix-M) changes how well the vaccine works. It planned to enroll healthy adults and infants in Mali. However, the study was withdrawn before any participants were enrolled, so no r…
Matched conditions: MALARIA
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC